1. Stirrat GM. Recurrent miscarriage; definition and epidemiology. Lancet 1990; 348: 1402-1406. [
DOI:10.1016/0140-6736(90)92159-F]
2. Clark DA, Chaouat G, Wong K, Gorczynski RM, Kinsky R. Tolerance mechanisms in pregnancy: a reappraisal of the role of Class I paternal MHC antigens. Am J Reprod Immunol 2010; 63: 93-103. [
DOI:10.1111/j.1600-0897.2009.00774.x]
3. Bidwell J, Keen L, Gallagher G, Kimberley R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: online databases. Genes Immunol 2001; 1: 3-19. [
DOI:10.1038/sj.gene.6363645]
4. Bobe P, Kannellopoulus-Langevin C, Bleux C, Voison GA. Modulation of mouse anti-SRBC antibody response by placental extracts II. Antigen specificity and regulatory role of B and T cell populations affected by two distinct placental fractions. J Immunol 1986; 136: 574-581.
5. Saini V, Arora S, Yadav A, Bhattacharjee J. Cytokines in recurrent pregnancy loss. Clin Chim Acta 2011; 412: 702-708. [
DOI:10.1016/j.cca.2011.01.002]
6. Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod immunol 2010; 64: 307-315. [
DOI:10.1111/j.1600-0897.2010.00864.x]
7. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001; 13: 219-228. [
DOI:10.1006/smim.2001.0316]
8. Daher S, Shulzhenko N, Morgun A, Mattar R, Rampim GF, Camano L, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol 2003; 58: 69-77. [
DOI:10.1016/S0165-0378(02)00059-1]
9. Kamali-Sarvestani E, Zolghadri J, Gharesi-Fard B, Sarvari J. Cytokine gene polymorphisms and susceptibility to recurrent pregnancy loss in Iranian women. J Reprod Immunol 2005; 65: 171-178. [
DOI:10.1016/j.jri.2005.01.008]
10. Babbage SJ, Arkwright PD, Vince GS, Perrey C, Pravica V, Quenby S, et al. Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss. J Reprod Immunol 2001; 1: 21-27. [
DOI:10.1016/S0165-0378(01)00069-9]
11. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000; 85: 1334-1339. [
DOI:10.1210/jcem.85.3.6555]
12. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376. [
DOI:10.1172/JCI2629]
13. Radoi VE. Biological markers of poor prognosis in pregnancy outcome- clinical and molecular correlations. Presented for PhD., Bucharest, "Carol Davila" University of Medicine and Pharmacy.2012.
14. Zammiti W, Mtiraoui N, Khairi H, Gris JC, Almawi WY, Mahjoub T. Associations between tumor necrosis factor-alpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage. Reproduction 2008; 135: 397-393. [
DOI:10.1530/REP-07-0322]
15. Olomolaiye O, Wood NAP, Bidwell JL. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet 1998; 25: 267. [
DOI:10.1111/j.1744-313X.1998.tb01147.x]
16. Chaouat G, Zourbas S, Ostojic S, Lappree- Delage G, Dubanchet S, Ledee N, et al. A brief review of recent data on some cytokine expression at the materno – foetal interface which might challenge the classical Th1/ Th2 dichotomy. J Reprod Immunol 2002; 53: 241-256. [
DOI:10.1016/S0165-0378(01)00119-X]
17. Costeas PA, Koumouli A, Giantsiou-Kyriakou A, Papaloizou A, Koumas L. Th2/Th3 cytokine genotypes are associated with pregnancy loss. Hum Immunol 2004; 65: 135-141. [
DOI:10.1016/j.humimm.2003.11.007]
18. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000; 1: 231-233. [
DOI:10.1038/sj.gene.6363666]
19. Crilly A, Hamilton J, Clark CJ, Jardine A and Madhok R. Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford) 2003; 42: 1295-1298. [
DOI:10.1093/rheumatology/keg420]
20. Makhseed M, Raghupathy R, Azizieh F, Omu A, Al-Shamali E and Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum Reprod 2001; 16: 2219-2226. [
DOI:10.1093/humrep/16.10.2219]
21. Austgulen R, Lien E, Liabakk NB, Jacobsen G, Arntzen KJ. Increased levels of cytokines and cytokine activity modifiers in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1994; 57: 149-155. [
DOI:10.1016/0028-2243(94)90291-7]
22. Von Wollf M, Thaler CJ, Strowitzki T, Broome J, Stolz W, Tabibzadeh S. Regulated expression of cytokines in human endometrium throughout the menstrual cycle: dysregulation in habitual abortion. Mol Hum Reprod 2000; 6: 227-234.
23. Hayakawa T, Takamura T, Hisada A, Abe T, Nomura G, Kobayashi K. IL-6 gene polymorphism -174G/C does not contribute substantially to hyperlipidaemia and Type II diabetes mellitus in Japanese men. Diabetologia 2002; 45: 453-454. [
DOI:10.1007/s00125-001-0722-4]
24. Zhai R, Liu G, Yang C. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a southern Chinese population. Pharmacogenetics 2001; 11: 699-701. [
DOI:10.1097/00008571-200111000-00008]
25. Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol 2004; 52: 36-41. [
DOI:10.1111/j.1600-0897.2004.00179.x]
26. Choi YK, Kwak-Kim J. Cytokine gene polymorphisms in recurrent spontaneous abortions: a comprehensive review. Am J Reprod Immunol 2008; 60: 91-110. [
DOI:10.1111/j.1600-0897.2008.00602.x]